.It's an uncommonly active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara ...
.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 trial, but the biotech s...
.Neurocrine Biosciences' mental illness course pivot has neglected. The biotech was not able to repl...
.Sanofi has made an overdue access to the radioligand gathering, paying 100 thousand euros ($ 110 th...
.After F2G's very first attempt to acquire a brand-new lesson of antifungal to market was actually d...
.Moderna has pledged to reduce R&D spending through $1.1 billion through 2027. The choice to shri...
.Merely 4 months after Sanofi bet $80 million in upfront cash on Pivot Therapeutics' losmapimod, the...
.Cancer cells firm Oncternal Therapeutics is actually folding all its own scientific trials as well ...
.Roche is storing out hopes that its injectable weight problems possibility can ultimately display 2...
.Novo Nordisk has lifted the cover on a phase 1 test of its own oral amylin and also GLP-1 receptor ...